Bristol-Myers Cancer Combo Has Tepid Result Against Chemotherapy

(Bloomberg) -- Bristol-Myers Squibb Co.’s blockbuster oncology drug showed tepid results in a trial of lung-cancer patients, in what investors may read as a setback in the competitive market drugs ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.